Canntab Therapeutics Limited announced that it has entered into a service agreement with Levitee Clinics Inc. Servicing over 35,000 patient visits in last 12 months, Levitee is establishing itself as a leader in the integrative wellness space. Levitee aims to transform mental health and addiction treatments through the integration of alternative medicinal therapies. Levitee also operates three pharmacies in Alberta specializing in filling prescriptions for patients with substance use disorders, mental health conditions and chronic pain. Canntab's full suite of oral tablet products including a comprehensive range of both THC and CBD strengths will be made available to Levitee and their patients. Both Canntab and Levitee believe that a hard tablet delivery format will be the preferred dosage format by many of Levitee's patients including more specifically the senior demographic and patients with several issues related to the use of Opiates and other related painkillers, who are largely interested in a product that is easy to administer and is also titratable due to the availability of multiple strengths. On November 11, 2021, Canntab received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers. The amendment marked the final regulatory step required to launch the Company's direct to consumer website, allowing patients across Canada with an authorized medical document to immediately order Canntab's unique patented exact dosage tablets and caplets of THC and CBD in various strengths online. Exact dosing and ease of administration are the key elements in the Canntab offering, which specifically addresses the needs of the medical community and patients.